Continuous edge Leverage CONTINUUS’s Integrated Continuous Manufacturing platform as a differentiator to target pharmaceutical and biotech firms seeking end-to-end continuous production capabilities, offering faster time-to-market and reduced waste compared to traditional batch processes.

Global affordability Position ICM as a solution for improving global access to medicines by reducing manufacturing costs and lead times, appealing to health systems, governments, and NGOs facing drug shortages and budget constraints.

Strategic partnerships Target large manufacturers and contractors (e.g., contract manufacturers, construction partners like Skanska) for joint-venture production facilities or CMOs that can deploy ICM at scale, accelerating customer adoption and facility buildouts.

Defense and public sector Highlight existing and potential government contracts (e.g., Department of Defense) as referenceable wins to enter conversations with other public sector buyers and to demonstrate capability in secure, mission-critical supply chains.

Growth signals Capitalize on recent leadership additions and recognized industry awards to support credibility in BD outreach, and align with potential enterprise customers seeking proven leadership and credible governance in innovative manufacturing tech.